Federation des caisses Desjardins du Quebec’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $167K | Sell |
33,091
-12,000
| -27% | -$60.7K | ﹤0.01% | 1264 |
|
|
2025
Q1 | $239K | Buy |
45,091
+2,000
| +5% | +$10.6K | ﹤0.01% | 1144 |
|
|
2024
Q4 | $291K | Buy |
43,091
+591
| +1% | +$4K | ﹤0.01% | 1074 |
|
|
2024
Q3 | $280K | Sell |
42,500
-3,500
| -8% | -$23.1K | ﹤0.01% | 1076 |
|
|
2024
Q2 | $345K | Hold |
46,000
| – | – | ﹤0.01% | 1018 |
|
|
2024
Q1 | $459K | Buy |
46,000
+1,900
| +4% | +$18.9K | ﹤0.01% | 902 |
|
|
2023
Q4 | $435K | Hold |
44,100
| – | – | ﹤0.01% | 805 |
|
|
2023
Q3 | $337K | Buy |
+44,100
| New | +$337K | ﹤0.01% | 830 |
|